Shree Ganesh Bio

17
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE051N01026
  • NSEID:
  • BSEID: 539470
INR
0.64
0.00 (0.00%)
BSENSE

Feb 13

BSE+NSE Vol: 4.53 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 13.22% vs -67.53% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -424.65% vs -109.34% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -55.15% vs -69.55% in Mar 2024

Compare Profit and Loss Results of Shree Ganesh Bio
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
22.00
2.00
20.00
1,000.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
22.00
2.00
20.00
1,000.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
0.00
-2.00
0%
Raw Materials Consumed
25.00
0.00
25.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
1.00
-1.00
-100.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
24.00
2.00
22.00
1,100.00%
Operating Profit (PBDIT) excl Other Income
-1.00
0.00
-1.00
0%
Other Income
1.00
0.00
1.00
0%
Operating Profit (PBDIT)
0.00
0.00
0.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
0.00
0.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
17.00
47.00
-30.00
-63.83%
Profit Available for appropriations
17.00
47.00
-30.00
-63.83%
Appropriations
17.00
47.00
-30.00
-63.83%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.01
0.45
-0.44
-97.78%
Profit And Loss - Net Sales
Net Sales 22.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.22% vs -67.53% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -424.65% vs -109.34% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.28 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -55.15% vs -69.55% in Mar 2024